Lipid raft-mediated regulation of hyaluronan-CD44 interactions in inflammation and cancer

Frontiers in Immunology

Volumn 6, Issue AUG, 2015, Pages

  Murai, Toshiyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

A disintegrin and metalloproteinase; Cholesterol; Ectodomain shedding; Extracellular matrix remodeling; Membrane dynamics; Membrane raft; Oligosaccharides; Transmembrane signaling

Indexed keywords

CHOLESTEROL; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOSAMINOGLYCAN; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE;

BIOSYNTHESIS; CANCER CELL; CANCER GROWTH; CANCER THERAPY; CELL ADHESION; CELL DIVISION; CELL MIGRATION; DRUG INTERACTION; ENZYMATIC DEGRADATION; GENE OVEREXPRESSION; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATION; LIPID RAFT; NEOPLASM; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REVIEW; X RAY CRYSTALLOGRAPHY;

EID: 84941277992     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00420     Document Type: Review

References (126)

1. Fraser JRE, Laurent TC, Laurent UBG. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med (1997) 242:27-33. doi: 10.1046/j.1365-2796.1997.00170.x.
2. Meyer K, Palmer JW. The polysaccharide of the vitreous humor. J Biol Chem (1934) 107:629-34.
3. Balazs EA, Delinger JL. Sodium hyaluronate and joint function. J Equine Vet Sci (1985) 5:217-28. doi:10.1016/S0737-0806(85)80102-7.
4. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer (2004) 4:528-39. doi:10.1038/nrc1391.
5. Pandey MS, Baggenstoss BA, Washburn J, Harris EN, Weigel PH. The hyaluronan receptor for endocytosis (HARE) activates NF-κB-mediated gene expression in response to 40-400-kDa, but not smaller or larger, hyaluronans. J Biol Chem (2013) 288:14068-79. doi:10.1074/jbc. M112.442889.
6. Tian X, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, et al. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature (2013) 499:346-9. doi:10.1038/nature12234.
7. Scott JE, Cummings C, Brass A, Chen Y. Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer simulation. Hyaluronan is a very efficient network-forming polymer. Biochem J (1991) 274:699-705.
8. Maroudas A, Weinberg PD, Parker KH, Winlove CP. The distributions and diffusivities of small ions in chondroitin sulphate, hyaluronate and some proteoglycan solutions. Biophys Chem (1988) 32:257-70. doi:10.1016/0301-4622(88)87012-1.
9. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem (1997) 272:13997-4000. doi:10.1074/jbc.272.22.13997.
10. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem (1999) 274:25085-92. doi:10.1074/jbc.274.35.25085.
11. Pienimäki JP, Rilla K, Fülöp C, Sironen RK, Karvinen S, Pasonen S, et al. Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan. J Biol Chem (2001) 276:20428-35. doi:10.1074/jbc. M007601200.
12. Li L, Asteriou T, Bernert B, Heldin CH, Heldin P. Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. Biochem J (2007) 404:327-36. doi:10.1042/BJ20061757.
13. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev (2011) 91:221-64. doi:10.1152/physrev.00052.2009.
14. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol (2004) 83:317-25. doi:10.1078/0171-9335-00392.
15. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology (2003) 13:105R-15R. doi:10.1093/glycob/cwg112.
16. Stern R, Jedrzejas MJ. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev (2006) 106:818-39. doi:10.1021/cr050247k.
17. Frost GI, Csóka TB, Wong T, Stern R. Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun (1997) 236:10-5. doi:10.1006/bbrc.1997.6773.
18. Lepperdinger G, Strobl B, Kreil G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem (1998) 273:22466-70. doi:10.1074/jbc.273.35.22466.
19. Gao F, Koenitzer JR, Tobolewski JM, Jiang D, Liang J, Noble PW, et al. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J Biol Chem (2008) 283:6058-66. doi:10.1074/jbc. M709273200.
20. Puré E, Assoian RK. Rheostatic signaling by CD44 and hyaluronan. Cell Signal (2009) 21:651-5. doi:10.1016/j.cellsig.2009.01.024.
21. Muto J, Yamasaki K, Taylor KR, Gallo RL. Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol (2009) 47:449-56. doi:10.1016/j.molimm.2009.08.026.
22. McBride WH, Bard JB. Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J Exp Med (1979) 149:507-15. doi:10.1084/jem.149.2.507.
23. Feinberg RN, Beebe DC. Hyaluronate in vasculogenesis. Science (1983) 220:1177-9. doi:10.1126/science.6857242.
24. Sugahara KN, Murai T, Nishinakamura H, Kawashima H, Saya H, Miyasaka M. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem (2003) 278:32259-65. doi:10.1074/jbc. M300347200.
25. Slomiany MG, Dai L, Tolliver LB, Grass GD, Zeng Y, Toole BP. Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides. Clin Cancer Res (2009) 15:7593-601. doi:10.1158/1078-0432.CCR-09-2317.
26. Slomiany MG, Dai L, Bomar PA, Knackstedt TJ, Kranc DA, Tolliver L, et al. Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides. Cancer Res (2009) 69:4992-8. doi:10.1158/0008-5472.CAN-09-0143.
27. Slomiany MG, Grass GD, Robertson AD, Yang XY, Maria BL, Beeson C, et al. Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells. Cancer Res (2009) 69:1293-301. doi:10.1158/0008-5472.CAN-08-2491.
28. Gilg AG, Tye SL, Tolliver LB, Wheeler WG, Visconti RP, Duncan JD, et al. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors. Clin Cancer Res (2008) 14:1804-13. doi:10.1158/1078-0432.CCR-07-1228.
29. Misra S, Toole BP, Ghatak S. Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. J Biol Chem (2006) 281:34936-41. doi:10.1074/jbc. C600138200.
30. Ghatak S, Misra S, Toole BP. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J Biol Chem (2005) 280:8875-83. doi:10.1074/jbc. M410882200.
31. Ghatak S, Misra S, Toole BP. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem (2002) 277:38013-20. doi:10.1074/jbc. M202404200.
32. Yang C, Cao M, Liu H, He Y, Xu J, Du Y, et al. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem (2012) 287:43094-107. doi:10.1074/jbc. M112.349209.
33. Duterme C, Mertens-Strijthagen J, Tammi M, Flamion B. Two novel functions of hyaluronidase-2 (Hyal2) are formation of the glycocalyx and control of CD44-ERM interactions. J Biol Chem (2009) 284:33495-508. doi:10.1074/jbc. M109.044362.
34. Wiranowska M, Ladd S, Moscinski LC, Hill B, Haller E, Mikecz K, et al. Modulation of hyaluronan production by CD44 positive glioma cells. Int J Cancer (2010) 127:532-42. doi:10.1002/ijc.25085.
35. Takahashi Y, Li L, Kamiryo M, Asteriou T, Moustakas A, Yamashita H, et al. Hyaluronan fragments induce endothelial cell differentiation in a CD44-and CXCL1/GRO1-dependent manner. J Biol Chem (2005) 280:24195-204. doi:10.1074/jbc. M411913200.
36. Tolg C, Telmer P, Turley E. Specific sizes of hyaluronan oligosaccharides stimulate fibroblast migration and excisional wound repair. PLoS One (2014) 9:e88479. doi:10.1371/journal.pone.0088479.
37. Slevin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem (2002) 277:41046-59. doi:10.1074/jbc. M109443200.
38. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem (2004) 279:17079-84. doi:10.1074/jbc. M310859200.
39. Fieber C, Baumann P, Vallon R, Termeer C, Simon JC, Hofmann M, et al. Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J Cell Sci (2004) 117:359-67. doi:10.1242/jcs.00831.
40. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol (2000) 165:1863-70. doi:10.4049/jimmunol.165.4.1863.
41. Kothapalli D, Flowers J, Xu T, Puré E, Assoian RK. Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44. J Biol Chem (2008) 283:31823-9. doi:10.1074/jbc. M802934200.
42. Saito T, Kawana H, Azuma K, Toyoda A, Fujita H, Kitagawa M, et al. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane. Int J Oncol (2011) 39:1311-20. doi:10.3892/ijo.2011.1114.
43. Schommer NN, Muto J, Nizet V, Gallo RL. Hyaluronan breakdown contributes to immune defense against group A Streptococcus. J Biol Chem (2014) 289:26914-21. doi:10.1074/jbc. M114.575621.
44. Hill DR, Rho HK, Kessler SP, Amin R, Homer CR, McDonald C, et al. Human milk hyaluronan enhances innate defense of the intestinal epithelium. J Biol Chem (2013) 288:29090-104. doi:10.1074/jbc. M113.468629.
45. Hill DR, Kessler SP, Rho HK, Cowman MK, de la Motte CA. Specific-sized hyaluronan fragments promote expression of human β-defensin 2 in intestinal epithelium. J Biol Chem (2012) 287:30610-24. doi:10.1074/jbc. M112.356238.
46. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest (1996) 98:2403-13. doi:10.1172/JCI119054.
47. Sokolowska M, Chen LY, Eberlein M, Martinez-Anton A, Liu Y, Alsaaty S, et al. Low molecular weight hyaluronan activates cytosolic phospholipase A2a and eicosanoid production in monocytes and macrophages. J Biol Chem (2014) 289:4470-88. doi:10.1074/jbc. M113.515106.
48. Powell JD, Horton MR. Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res (2005) 31:207-18. doi:10.1385/IR:31:3:207.
49. Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res (1997) 71:241-319. doi:10.1016/S0065-230X(08)60101-3.
50. Naor D, Nedvetzki S. CD44 in rheumatoid arthritis. Arthritis Res Ther (2003) 5:105-15. doi:10.1186/ar735.
51. Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol (2008) 18:260-7. doi:10.1016/j.semcancer.2008.03.015.
52. Hertweck MK, Erdfelder F, Kreuzer KA. CD44 in hematological neoplasias. Ann Hematol (2011) 90:493-508. doi:10.1007/s00277-011-1161-z.
53. Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol (1992) 117:1343-50. doi:10.1083/jcb.117.6.1343.
54. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol (1999) 144:789-801. doi:10.1083/jcb.144.4.789.
55. Zhou B, Weigel JA, Saxena A, Weigel PH. Molecular cloning and functional expression of the rat 175-kDa hyaluronan receptor for endocytosis. Mol Biol Cell (2002) 13:2853-68. doi:10.1091/mbc.02-03-0048.
56. Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science (1972) 175:720-31. doi:10.1126/science.175.4023.720.
57. Simons K, van Meer G. Lipid sorting in epithelial cells. Biochemistry (1988) 27:6197-202. doi:10.1021/bi00417a001.
58. Simons K, Ikonen E. Functional rafts in cell membranes. Nature (1997) 387:569-72. doi:10.1038/42408.
59. Brown DA, Rose JK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell (1992) 68:533-44. doi:10.1016/0092-8674(92)90189-J.
60. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science (2010) 327:46-50. doi:10.1126/science.1174621.
61. Resh MD. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta (1999) 1451:1-16. doi:10.1016/S0167-4889(99)00075-0.
62. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol (2000) 1:31-9. doi:10.1038/35036205.
63. Suzuki KG, Kasai RS, Hirosawa KM, Nemoto YL, Ishibashi M, Miwa Y, et al. Transient GPI-anchored protein homodimers are units for raft organization and function. Nat Chem Biol (2012) 8:774-83. doi:10.1038/nchembio.1028.
64. Sevcsik E, Brameshuber M, Fölser M, Weghuber J, Honigmann A, Schütz GJ. GPI-anchored proteins do not reside in ordered domains in the live cell plasma membrane. Nat Commun (2015) 6:6969. doi:10.1038/ncomms7969.
65. Brown DA, London E. Structure and function of sphingolipid-and cholesterol-rich membrane rafts. J Biol Chem (2000) 275:17221-4. doi:10.1074/jbc. R000005200.
66. Fessler MB, Parks JS. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol (2011) 187:1529-35. doi:10.4049/jimmunol.1100253.
67. Vainio S, Heino S, Månsson JE, Fredman P, Kuismanen E, Vaarala O, et al. Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae. EMBO Rep (2002) 3:95-100. doi:10.1093/embo-reports/kvf010.
68. Hofman EG, Ruonala MO, Bader AN, van den Heuvel D, Voortman J, Roovers RC, et al. EGF induces coalescence of different lipid rafts. J Cell Sci (2008) 121:2519-28. doi:10.1242/jcs.028753.
69. Hanzal-Bayer MF, Hancock JF. Lipid rafts and membrane traffic. FEBS Lett (2007) 581:2098-104. doi:10.1016/j.febslet.2007.03.019.
70. Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol (2012) 196:395-406. doi:10.1083/jcb.201102147.
71. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (2011) 144:646-74. doi:10.1016/j.cell.2011.02.013.
72. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer (2003) 3:362-74. doi:10.1038/nrc1075.
73. Huovila AP, Turner AJ, Pelto-Huikko M, Kärkkäinen I, Ortiz RM. Shedding light on ADAM metalloproteinases. Trends Biochem Sci (2005) 30:413-22. doi:10.1016/j.tibs.2005.05.006.
74. Alfandari D, McCusker C, Cousin H. ADAM function in embryogenesis. Semin Cell Dev Biol (2009) 20:153-63. doi:10.1016/j.semcdb.2008.09.006.
75. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, et al. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res (1998) 58:342-7.
76. Setälä LP, Tammi MI, Tammi RH, Eskelinen MJ, Lipponen PK, Ågren UM, et al. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer (1999) 79:1133-8. doi:10.1038/sj.bjc.6690180.
77. Auvinen P, Tammi R, Parkkinen J, Tammi M, Ågren U, Johansson R, et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol (2000) 156:529-36. doi:10.1016/S0002-9440(10)64757-8.
78. Saari H, Konttinen YT. Determination of synovial fluid hyaluronate concentration and polymerisation by high performance liquid chromatography. Ann Rheum Dis (1989) 48:565-70. doi:10.1136/ard.48.7.565.
79. Lokeshwar VB, Obek C, Soloway MS, Block NL. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res (1997) 57:773-7.
80. Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, Block NL, et al. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem (2001) 276:11922-32. doi:10.1074/jbc. M008432200.
81. Murai T, Miyauchi T, Yanagida T, Sako Y. Epidermal growth factor-regulated activation of Rac GTPase enhances CD44 cleavage by metalloproteinase disintegrin ADAM10. Biochem J (2006) 395:65-71. doi:10.1042/BJ20050582.
82. Kuo YC, Su CH, Liu CY, Chen TH, Chen CP, Wang HS. Transforming growth factor-β induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase. Int J Cancer (2009) 124:2568-76. doi:10.1002/ijc.24263.
83. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol (2001) 153:893-904. doi:10.1083/jcb.153.5.893.
84. Suenaga N, Mori H, Itoh Y, Seiki M. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene (2005) 24:859-68. doi:10.1038/sj.onc.1208258.
85. + progenitor cell retention, egress, and mobilization. J Clin Invest (2009) 119:492-503. doi:10.1172/JCI36541.
86. Murai T, Miyazaki Y, Nishinakamura H, Sugahara KN, Miyauchi T, Sako Y, et al. Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J Biol Chem (2004) 279:4541-50. doi:10.1074/jbc. M307356200.
87. Murai T. The role of lipid rafts in cancer cell adhesion and migration. Int J Cell Biol (2012) 2012:763283. doi:10.1155/2012/763283.
88. Murai T. Cholesterol lowering: role in cancer prevention and treatment. Biol Chem (2015) 396:1-11. doi:10.1515/hsz-2014-0194.
89. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol (1993) 54:271-335. doi:10.1016/S0065-2776(08)60537-4.
90. Ilangumaran S, Hoessli DC. Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem J (1998) 335:433-40.
91. Oliferenko S, Paiha K, Harder T, Gerke V, Schwärzler C, Schwarz H, et al. Analysis of CD44-containing lipid rafts: recruitment of annexin II and stabilization by the actin cytoskeleton. J Cell Biol (1999) 146:843-54. doi:10.1083/jcb.146.4.843.
92. Gómez-Moutón C, Abad JL, Mira E, Lacalle RA, Gallardo E, Jiménez-Baranda S, et al. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci U S A (2001) 98:9642-7. doi:10.1073/pnas.171160298.
93. Bourguignon LY, Singleton PA, Diedrich F, Stern R, Gilad E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem (2004) 279:26991-7007. doi:10.1074/jbc. M311838200.
94. Grass GD, Tolliver LB, Bratoeva M, Toole BP. CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness. J Biol Chem (2013) 288:26089-104. doi:10.1074/jbc. M113.497685.
95. Babina IS, McSherry EA, Donatello S, Hill AD, Hopkins AM. A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44. Breast Cancer Res (2014) 16:R19. doi:10.1186/bcr3614.
96. Lee JL, Wang MJ, Sudhir PR, Chen JY. CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts. Mol Cell Biol (2008) 28:5710-23. doi:10.1128/MCB.00186-08.
97. Murai T, Maruyama Y, Mio K, Nishiyama H, Suga M, Sato C. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J Biol Chem (2011) 286:1999-2007. doi:10.1074/jbc. M110.184010.
98. Kim KB, Yi JS, Nguyen N, Lee JH, Kwon YC, Ahn BY, et al. Cell-surface receptor for complement component C1q (gC1qR) is a key regulator for lamellipodia formation and cancer metastasis. J Biol Chem (2011) 286:23093-101. doi:10.1074/jbc. M111.233304.
99. Singh V, Erb U, Zöller M. Cooperativity of CD44 and CD49d in leukemia cell homing, migration, and survival offers a means for therapeutic attack. J Immunol (2013) 191:5304-16. doi:10.4049/jimmunol.1301543.
100. Midgley AC, Rogers M, Hallett MB, Clayton A, Bowen T, Phillips AO, et al. Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. J Biol Chem (2013) 288:14824-38. doi:10.1074/jbc. M113.451336.
101. Andre B, Duterme C, Van Moer K, Mertens-Strijthagen J, Jadot M, Flamion B. Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raft-associated hyaluronidase. Biochem Biophys Res Commun (2011) 411:175-9. doi:10.1016/j.bbrc.2011.06.125.
102. Kultti A, Rilla K, Tiihonen R, Spicer AP, Tammi RH, Tammi MI. Hyaluronan synthesis induces microvillus-like cell surface protrusions. J Biol Chem (2006) 281:15821-8. doi:10.1074/jbc. M512840200.
103. Triantafilou M, Miyake K, Golenbock DT, Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci (2002) 115:2603-11.
104. Grass GD, Dai L, Qin Z, Parsons C, Toole BP. CD147: regulator of hyaluronan signaling in invasiveness and chemoresistance. Adv Cancer Res (2014) 123:351-73. doi:10.1016/B978-0-12-800092-2.00013-7.
105. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell (1994) 76:301-14. doi:10.1016/0092-8674(94)90337-9.
106. DeGrendele HC, Estess P, Picker LJ, Siegelman MH. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med (1996) 183:1119-30. doi:10.1084/jem.183.3.1119.
107. Clark RA, Alon R, Springer TA. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol (1996) 134:1075-87. doi:10.1083/jcb.134.4.1075.
108. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science (1997) 278:672-5. doi:10.1126/science.278.5338.672.
109. Firan M, Dhillon S, Estess P, Siegelman MH. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood (2006) 107:619-27. doi:10.1182/blood-2005-06-2277.
110. Lesley J, Howes N, Perschl A, Hyman R. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med (1994) 180:383-7. doi:10.1084/jem.180.1.383.
111. Ariel A, Lider O, Brill A, Cahalon L, Savion N, Varon D, et al. Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators. Immunology (2000) 100:345-51. doi:10.1046/j.1365-2567.2000.00059.x.
112. Maeshima N, Poon GF, Dosanjh M, Felberg J, Lee SSM, Cross JL, et al. Hyaluronan binding identifies the most proliferative activated and memory T cells. Eur J Immunol (2011) 41:1108-19. doi:10.1002/eji.201040870.
113. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med (1995) 182:419-29. doi:10.1084/jem.182.2.419.
114. English NM, Lesley JF, Hyman R. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res (1998) 58:3736-42.
115. Skelton TP, Zeng C, Nocks A, Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol (1998) 140:431-46. doi:10.1083/jcb.140.2.431.
116. Levesque MC, Haynes BF. TNF-α and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44. Cell Immunol (1999) 193:209-18. doi:10.1006/cimm.1999.1456.
117. Ruffell B, Poon GF, Lee SS, Brown KL, Tjew SL, Cooper J, et al. Differential use of chondroitin sulfate to regulate hyaluronan binding by receptor CD44 in inflammatory and interleukin 4-activated macrophages. J Biol Chem (2011) 286:19179-90. doi:10.1074/jbc. M110.200790.
118. Maiti A, Maki G, Johnson P. TNF-α induction of CD44-mediated leukocyte adhesion by sulfation. Science (1998) 282:941-3. doi:10.1126/science.282.5390.941.
119. Brown KL, Maiti A, Johnson P. Role of sulfation in CD44-mediated hyaluronan binding induced by inflammatory mediators in human CD14+ peripheral blood monocytes. J Immunol (2001) 167:5367-74. doi:10.4049/jimmunol.167.9.5367.
120. Murai T, Sato C, Sato M, Nishiyama H, Suga M, Mio K, et al. Membrane cholesterol modulates the hyaluronan-binding ability of CD44 in T lymphocytes and controls rolling under shear flow. J Cell Sci (2013) 126:3284-94. doi:10.1242/jcs.120014.
121. Teriete P, Banerji S, Noble M, Blundell CD, Wright AJ, Pickford AR, et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell (2004) 13:483-96. doi:10.1016/S1097-2765(04)00080-2.
122. Banerji S, Wright AJ, Noble M, Mahoney DJ, Campbell ID, Day AJ, et al. Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat Struct Mol Biol (2007) 14:234-9. doi:10.1038/nsmb1201.
123. Favreau AJ, Faller CE, Guvench O. CD44 receptor unfolding enhances binding by freeing basic amino acids to contact carbohydrate ligand. Biophys J (2013) 105:1217-26. doi:10.1016/j.bpj.2013.07.041.
124. Hryniewicz-Jankowska A, AugoffK, Biernatowska A, Podkalicka J, Sikorski AF. Membrane rafts as a novel target in cancer therapy. Biochim Biophys Acta (2014) 1845:155-65. doi:10.1016/j.bbcan.2014.01.006.
125. Dalla Pozza E, Lerda C, Costanzo C, Donadelli M, Dando I, Zoratti E, et al. Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity. Biochim Biophys Acta (2013) 1828:1396-404. doi:10.1016/j.bbamem.2013.01.020.
126. Qhattal HS, Liu X. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. Mol Pharm (2011) 8:1233-46. doi:10.1021/mp2000428.